EUVIMEDEUVIMED entdecken
Crossref

Perinatal, metabolic, and reproductive features in PPARG -related lipodystrophy

Camille Gosseaume, Thierry Fournier, Isabelle Jéru, Marie-Léone Vignaud, Isabelle Missotte, Françoise Archambeaud, Xavier Debussche, Céline Droumaguet, Bruno Fève, Sophie Grillot, Bruno Guerci, Sylvie Hieronimus und 10 weitere

European Journal of Endocrinology · 2023

DOI: 10.1093/ejendo/lvad023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2023. Verfasst von Camille Gosseaume und 21 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne University, Inserm U938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris 75012, France. Hauptthemen laut MEDLINE: Pancreatitis, Lipodystrophy, Hypertriglyceridemia, Hypertension. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: French Ministry of Solidarity and Health, Assistance-Publique Hôpitaux de Paris, Sorbonne University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The adipogenic PPARG-encoded PPARγ nuclear receptor also displays essential placental functions. We evaluated the metabolic, reproductive, and perinatal features of patients with PPARG-related lipodystrophy.

Methods

Current and retrospective data were collected in patients referred to a National Rare Diseases Reference Centre.

Results

26 patients from 15 unrelated families were studied (18 women, median age 43 years). They carried monoallelic PPARG variants except a homozygous patient with congenital generalized lipodystrophy. Among heterozygous patients aged 16 or more (n = 24), 92% had diabetes, 96% partial lipodystrophy (median age at diagnosis 24 and 37 years), 78% hypertriglyceridaemia, 71% liver steatosis, and 58% hypertension. The mean BMI was 26 ± 5.0 kg/m2. Women (n = 16) were frequently affected by acute pancreatitis (n = 6) and/or polycystic ovary syndrome (n = 12). Eleven women obtained one or several pregnancies, all complicated by diabetes (n = 8), hypertension (n = 4), and/or hypertriglyceridaemia (n = 10). We analysed perinatal data of patients according to the presence (n = 8) or absence (n = 9) of a maternal dysmetabolic environment. The median gestational age at birth was low in both groups (37 and 36 weeks of amenorrhea, respectively). As expected, the birth weight was higher in patients exposed to a foetal dysmetabolic environment of maternal origin. In contrast, 85.7% of non-exposed patients, in whom the variant is, or is very likely to be, paternally-inherited, were small for gestational age.

Conclusions

Lipodystrophy-related PPARG variants induce early metabolic complications. Our results suggest that placental expression of PPARG pathogenic variants carried by affected foetuses could impair prenatal growth and parturition. This justifies careful pregnancy monitoring in affected families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisLipodystrophyHypertriglyceridemiaHypertensionInfant, NewbornHumansFemalePregnancyAdultPPAR gammaRetrospective StudiesAcute DiseasePlacentaParturition

Stichwörter der Autor:innen

PPARGhomozygous PPARG variant‌lipodystrophyplacentapregnancy

Substanzen

PPAR gamma

Autor:innen und Institutionen

  • Sorbonne University, Inserm U938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris 75012, France.
  • Université Paris Cité, Inserm, 3PHM, Pathophysiology and Pharmacotoxicology of the Human Placenta, Pre & Post Natal Microbiota, Paris, F-75006, France.
  • Department of Molecular Biology and Genetics, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, Paris, France.
  • Department of Pediatrics, Territorial Hospital Center, Nouméa, New Caledonia, France.
  • Department of Endocrinology, Limoges University Hospital, Limoges, France.
  • Clinical Investigation and Clinical Epidemiology Center (CIC-EC INSERM/CHU/University), Reunion Island University Hospital, Saint-Denis de la Réunion, France.

ORCID-Profile: Christine Poitou, Vassilis Tsatsaris, Corinne Vigouroux, Camille Vatier

Förderung

  • French Ministry of Solidarity and Health
  • Assistance-Publique Hôpitaux de Paris
  • Sorbonne University
  • Inserm
  • ICAN
  • Fondation pour la Recherche Médicale, France

Zitieren

APA

Gosseaume, C., Fournier, T., Jéru, I., Vignaud, M. L., Missotte, I., Archambeaud, F., Debussche, X., Droumaguet, C., Fève, B., Grillot, S., Guerci, B., Hieronimus, S., Horsmans, Y., Nobécourt, E., Pienkowski, C., Poitou, C., Thissen, J. P., Lascols, O., Degrelle, S., …, & Vatier, C. (2023). Perinatal, metabolic, and reproductive features in PPARG -related lipodystrophy. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvad023

Vancouver

Gosseaume C, Fournier T, Jéru I, Vignaud ML, Missotte I, Archambeaud F, et al. Perinatal, metabolic, and reproductive features in PPARG -related lipodystrophy. European Journal of Endocrinology. 2023. doi:10.1093/ejendo/lvad023

BibTeX
@article{Gosseaume2023,
  author = {Gosseaume, Camille and Fournier, Thierry and Jéru, Isabelle and Vignaud, Marie-Léone and Missotte, Isabelle and Archambeaud, Françoise and Debussche, Xavier and Droumaguet, Céline and Fève, Bruno and Grillot, Sophie and Guerci, Bruno and Hieronimus, Sylvie and Horsmans, Yves and Nobécourt, Estelle and Pienkowski, Catherine and Poitou, Christine and Thissen, Jean-Paul and Lascols, Olivier and Degrelle, Séverine and Tsatsaris, Vassilis and Vigouroux, Corinne and Vatier, Camille},
  title = {Perinatal, metabolic, and reproductive features in PPARG -related lipodystrophy},
  journal = {European Journal of Endocrinology},
  year = {2023},
  doi = {10.1093/ejendo/lvad023}
}
Kostenlos starten →